Gan & Lee Pharmaceuticals.
Clinical trials sponsored by Gan & Lee Pharmaceuticals., explained in plain language.
-
New shot could help obese people breathe better at night without CPAP
Disease control Not yet recruitingThis study tests an experimental injection called GZR18 in 140 obese adults with moderate-to-severe obstructive sleep apnea who cannot or will not use a CPAP machine. The goal is to see if the drug improves breathing during sleep and helps with weight loss over 52 weeks. Particip…
Phase: PHASE3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New drug GLR2037 tested in men with advanced prostate cancer
Disease control Not yet recruitingThis early-phase study tests a new drug called GLR2037 in about 65 men with metastatic prostate cancer that has spread to bones or soft tissues. The main goal is to check the drug's safety and how the body processes it. Participants must have had prior hormone therapy and at leas…
Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Healthy men to test cheaper version of blockbuster allergy drug
Knowledge-focused Not yet recruitingThis study checks if a new drug, GLR1044, works the same as the approved drug Dupilumab (Dupixent®) in 198 healthy Chinese men. Each person gets one shot and is followed for 57 days to measure drug levels and safety. The goal is to see if GLR1044 can be a more affordable option f…
Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Knowledge-focused
Last updated May 01, 2026 16:01 UTC